Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Signs Value-Based Deal for Enbrel (AMGN)
Amgen Signs Value-Based Deal for Enbrel (AMGN)
Amgen Signs Value-Based Deal for Enbrel (AMGN)
Submitted by
admin
on February 23, 2017 - 9:39pm
Source:
Investopedia
News Tags:
Amgen
Enbrel
rheumatoid arthritis
Headline:
Amgen Signs Value-Based Deal for Enbrel (AMGN)
Do Not Allow Advertisers to Use My Personal information
